This is a treatment used for some cancers. It involves injecting special medicine along with a substance that blocks blood flow to the tumor. This helps stop the cancer from growing and can also help reduce swelling.
Every report comes from a Lived member, sent anonymously.
Have you had Chemoembolization for Hepatocellular Carcinoma?
Chemoembolization, usually called transarterial chemoembolization or TACE, is a cancer treatment given through a thin tube threaded into an artery. The doctor delivers chemotherapy straight into the vessels feeding a tumor, then blocks those vessels with an embolic agent, a material that plugs them. Blocking the vessels does two things: it keeps the drug concentrated in the tumor for longer, and it cuts off the blood that brings the tumor oxygen and nutrients. Because most of the drug stays in the tumor, the rest of the body gets much less of it than with chemotherapy given by vein. TACE is used mainly for tumors in the liver. The liver suits this approach because healthy liver tissue gets most of its blood from the portal vein, while liver tumors depend almost entirely on the hepatic artery. Blocking that artery therefore starves the tumor while most of the healthy liver keeps its blood supply. The most common reason for TACE is hepatocellular carcinoma, the most common type of primary liver cancer, especially at the intermediate stage: several tumors confined to the liver, in a person whose liver still works reasonably well. For that group, US liver specialists consider TACE the main treatment, because trials show it helps people live longer than supportive care alone. It is also used when surgery, a liver transplant or ablation (destroying a tumor with heat or cold) is not possible, and for some cancers that have spread to the liver from elsewhere, such as colon cancer or neuroendocrine tumors, though evidence for those uses is thinner. TACE controls tumors rather than curing them. It is usually not a good choice when liver function is poor, when tumor has grown into the portal vein, or when tumors fill much of the liver, because the chance of benefit falls and the risk of liver failure rises. Depending on the situation, alternatives include radioembolization (tiny radioactive beads placed through the same kind of catheter), focused radiation, or cancer medicines that work throughout the body.
Planning usually starts with a visit to the interventional radiologist, the specialist who performs the procedure, and recent CT or MRI scans to map the tumors and their blood supply. Blood tests check liver and kidney function and blood clotting, since these help decide whether TACE is safe and how much of the liver can be treated at once. Tell the team about every medicine and supplement you take. You may be asked to stop blood thinners, aspirin or anti-inflammatory pain relievers such as ibuprofen beforehand, and you will get specific instructions about your other medicines. Mention any allergies, particularly to the iodine-based contrast dye used in X-ray imaging, and any kidney problems or diabetes, because contrast can strain the kidneys. A history of bile duct surgery, a bile duct stent or bile duct blockage matters too, because it raises the risk of infection in the liver afterward, and some teams give antibiotics ahead of time for this reason. If you will receive sedation, you will usually be asked not to eat or drink for several hours beforehand. Although some centers send people home the same day, plan for at least one night in the hospital, and arrange for someone to drive you home.
TACE is done in an interventional radiology suite using live X-ray guidance. A small IV line (a thin tube in a vein in the hand or arm) delivers sedation, which usually leaves people relaxed and drowsy without a breathing tube. Some people need general anesthesia instead. You may also be given medicines to prevent nausea, pain and infection. After numbing the skin, the doctor places a thin catheter into an artery in the groin or wrist and guides it up to the liver. Contrast dye injected through the catheter shows the vessels on the X-ray screen, and the doctor steers the catheter as close to the tumor's own branches as possible so that healthy liver is spared. The chemotherapy and embolic material are then injected, and further images confirm the tumor has been covered. You may feel pressure at the entry point and a brief warm feeling as the contrast passes, but the procedure is not usually painful. The chemotherapy may be mixed with an oily contrast agent (conventional TACE) or loaded onto tiny beads that release it slowly (drug-eluting bead TACE). Studies comparing the two have not shown one to be consistently better. The procedure usually takes about 90 minutes. Afterward the catheter is removed, and pressure or a small closure device seals the artery without stitches.
You will rest in a recovery area for two to six hours, depending on whether the groin or wrist was used. Most people then stay in the hospital for a day or two while pain and nausea are brought under control. In the first week, many people develop post-embolization syndrome: pain in the upper right abdomen, nausea, vomiting, fever and tiredness as the treated tumor tissue dies. It feels much like the flu, usually peaks in the first few days, and is treated with pain and anti-nausea medicine. A low fever can last up to a week, and fatigue and poor appetite can linger for two weeks or more. Most people return to normal activities within about a week, though this varies with how much of the liver was treated. Contact your care team right away if pain suddenly gets worse or changes in character, if a fever suddenly climbs higher rather than slowly settling, if your skin or the whites of your eyes turn yellow, if you become newly confused or unusually sleepy, if your belly swells, or if you notice any other unusual change. Sudden changes in pain or fever can signal infection or another complication, and the other signs can mean the liver is not coping with the treatment, which is easy to mistake for ordinary tiredness. A CT or MRI scan and blood tests about four to eight weeks later show how the tumor responded. Tumors in both halves of the liver are often treated in stages a month or two apart. If tumor remains or returns, TACE can usually be repeated. If tumors keep growing despite repeated sessions, doctors usually switch to another type of treatment.
Most people have some post-embolization symptoms, but serious complications occur in fewer than 1 in 10 treatments. The most important is liver failure, reported in about 3 to 5 percent of cases. It is more likely when liver function is already reduced, when tumor blocks the portal vein, or when a large part of the liver is treated at once, which is why careful selection and treating only the tumor's own branches matter so much. In reported results, between 0 and 4 percent of people died within 30 days of treatment. Other serious complications are uncommon. They include a liver abscess (a pocket of infection), which is more likely in people with bile duct stents, blockage or previous bile duct surgery; damage to the gallbladder, bile ducts or stomach lining if embolic material reaches the wrong place; and injury or bleeding at the artery entry site. The contrast dye can cause allergic reactions and can harm the kidneys, especially in people with diabetes or kidney disease. Because most of the chemotherapy stays in the liver, body-wide chemotherapy effects such as low blood counts or hair loss are usually mild. The more lasting trade-off is that each treatment injures some healthy liver, so repeated sessions can wear down liver function over time.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Chemoembolization, what to expect, or ask the community a question.